Skip to main content

Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11

Pfizer's application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.